Recurrent ischemic heart disease: the effect of advancing age

Area of Science:

• Cardiology
• Vascular Surgery
• Geriatric Medicine

Background:

• A significant number of patients develop recurrent ischemic heart disease after initial coronary artery revascularization.
• Evaluating the safety and efficacy of repeat procedures in an aging population is crucial.

Purpose of the Study:

• To assess the impact of advancing age on risk factors, morbidity, and mortality associated with repeat coronary artery revascularization.
• To determine if age is a contraindication for repeat surgical intervention.

Main Methods:

• Retrospective analysis of 168 patients evaluated for recurrent ischemic heart disease post-coronary artery revascularization between January 1, 1988, and June 30, 1992.
• Comparison of outcomes between patients undergoing non-operative management (44 patients) and repeat revascularization (124 patients).

Main Results:

• Advancing age was not found to be a contraindication for repeat coronary artery revascularization.
• The average interval between initial and repeat revascularization was eight years.
• Factors such as tobacco use, recent myocardial infarction, diabetes mellitus, and high cholesterol levels are indicators of recurrent disease and increased surgical risk.

Conclusions:

• Repeat coronary artery revascularization is a viable treatment option for elderly patients with recurrent ischemic heart disease.
• While younger patients show disease progression in various vascular beds, age itself does not preclude successful repeat revascularization.
• Identifying and managing risk factors is essential for optimizing outcomes in patients requiring repeat coronary artery revascularization.